Thermo Fisher Scientific ... (TMO)

NYSE: TMO · Real-Time Price · USD

419.32

-9.68 (-2.26%)

At close: May 01, 2025, 1:51 PM

Thermo Fisher Scientific Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	42.88B	42.86B	44.91B	39.21B	32.22B	25.54B	24.36B	20.92B	18.27B
Cost of Revenue	24.77B	25.74B	25.41B	18.98B	15.71B	13.71B	12.99B	10.96B	9.46B
Gross Profit	18.11B	17.11B	19.5B	20.23B	16.5B	11.83B	11.36B	9.96B	8.81B
Operating Income	7.34B	6.86B	8.39B	10.03B	7.79B	4.59B	3.78B	2.97B	2.45B
Interest Income	1.08B	879M	272M	43M	65M	224M	137M	81M	48.4M
Pretax Income	7.04B	6.3B	7.83B	8.84B	7.22B	4.07B	3.26B	2.43B	2.02B
Net Income	6.33B	6B	6.95B	7.72B	6.38B	3.7B	2.94B	2.23B	2.02B
Selling & General & Admin	8.6B	8.45B	7.13B	6.84B	5.76B	4.93B	4.82B	4.41B	4.04B
Research & Development	1.39B	1.34B	1.47B	1.41B	1.18B	1B	967M	888M	754.8M
Other Expenses	380M	472M	2.4B	1.76B	1.67B	1.71B	9M	-28M	-4.1M
Operating Expenses	10.72B	10.25B	10.99B	10.01B	8.61B	7.65B	7.53B	6.89B	6.18B
Interest Expense	1.39B	1.38B	726M	536M	553M	676M	667M	592M	469.6M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	35.54B	36B	36.41B	28.99B	24.32B	21.36B	20.52B	17.85B	15.64B
Income Tax Expense	657M	284M	703M	1.11B	850M	374M	324M	201M	-1.4M
Shares Outstanding (Basic)	382M	386M	392M	394M	396M	400M	402M	395M	394.8M
Shares Outstanding (Diluted)	383M	388M	394M	397M	399M	403M	406M	398M	397.4M
EPS (Basic)	16.58	15.53	17.73	19.61	16.10	9.24	7.31	5.64	5.12
EPS (Diluted)	16.53	15.45	17.64	19.46	15.98	9.17	7.24	5.59	5.09
EBITDA	11.54B	11.08B	11.94B	12.96B	10.19B	6.46B	6.2B	5.25B	4.25B
EBIT	8.43B	7.67B	8.56B	10.37B	7.87B	4.75B	3.93B	3.22B	2.49B
Depreciation & Amortization	3.11B	3.41B	3.38B	2.59B	2.33B	2.28B	2.27B	2.03B	1.76B